Author Correction: An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells

Correction to: Scientific Reports https://doi.org/10.1038/s41598-017-02456-y, published online 24 May 2017

The authors felt they should cite the following article by Ohashi M, et al. (2015), which is included below as Reference 1.

Specifically, in the Introduction the sentence,

“Recently, Li et al. have achieved high efficiency (8–76%) of genome editing by using an episomal vector to express Cas9 and gRNA23.”

should read:

“Recently, two groups have achieved high efficiency of genome editing by using an episomal vector to express Cas9 and gRNA in both human somatic cells and mouse iPSCs23, 1.”

In addition, in the Discussion, the sentence:

“When we were preparing the manuscript, another group reported that the episomal CRISPR/Cas9 system could work efficiently in HeLa cells and mouse iPSCs23.”

should read:

“Two groups have reported that the episomal CRISPR/Cas9 system could work efficiently in both human somatic cells and mouse iPSCs23, 1.”

References

  1. 1.

    Ohashi, M. et al. The EBNA3 Family of Epstein-Barr Virus Nuclear Proteins Associates with the USP46/USP12 Deubiquitination Complexes to Regulate Lymphoblastoid Cell Line Growth. PLoS Pathog 11(4), e1004822, https://doi.org/10.1371/journal.ppat.1004822 (2015).

Download references

Author information

Correspondence to Hongyan Wang or Yongming Wang.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.